Q3 EPS Forecast for Tenet Healthcare Increased by Analyst

Key Points

• Zacks Research Analysts have significantly increased Tenet Healthcare's Q3 2025 earnings per share estimate from $2.25 to $3.22, with a full-year earnings expectation of $12.24.
• Multiple analysts have updated their ratings and price targets for Tenet Healthcare, with UBS Group raising their target to $238.00 and Goldman Sachs adjusting theirs to $154.00.
• Tenet Healthcare has seen strong institutional interest, with hedge funds owning approximately 95.44% of its stock, indicating robust investor confidence.

Tenet Healthcare Corporation (NYSE:THC - Free Report) - Research analysts at Zacks Research boosted their Q3 2025 earnings estimates for shares of Tenet Healthcare in a research report issued on Tuesday, August 5th. Zacks Research analyst R. Department now anticipates that the company will earn $3.22 per share for the quarter, up from their previous forecast of $2.25. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare's Q4 2025 earnings at $4.01 EPS, FY2025 earnings at $15.62 EPS, Q2 2026 earnings at $3.50 EPS, Q3 2026 earnings at $3.57 EPS, Q4 2026 earnings at $4.04 EPS, FY2026 earnings at $14.70 EPS, Q1 2027 earnings at $3.83 EPS, Q2 2027 earnings at $4.43 EPS and FY2027 earnings at $17.05 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, beating the consensus estimate of $2.84 by $1.18. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. The firm had revenue of $5.27 billion for the quarter, compared to analysts' expectations of $5.16 billion. During the same period in the prior year, the firm earned $2.31 EPS. The business's revenue was up 3.2% on a year-over-year basis.

Several other research analysts have also recently commented on the stock. Morgan Stanley raised their target price on shares of Tenet Healthcare from $175.00 to $210.00 and gave the stock an "overweight" rating in a report on Monday, June 9th. Bank of America increased their price target on shares of Tenet Healthcare from $165.00 to $180.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Barclays reduced their price target on shares of Tenet Healthcare from $215.00 to $208.00 and set an "overweight" rating on the stock in a research report on Thursday, July 24th. Baird R W lowered shares of Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Finally, Wolfe Research lowered shares of Tenet Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $191.56.

Tenet Healthcare Stock Performance

Shares of THC traded up $2.28 during mid-day trading on Thursday, hitting $165.70. 734,141 shares of the company's stock were exchanged, compared to its average volume of 1,716,906. Tenet Healthcare has a 52 week low of $109.82 and a 52 week high of $185.25. The stock's 50-day simple moving average is $167.22 and its 200-day simple moving average is $147.25. The firm has a market cap of $14.64 billion, a price-to-earnings ratio of 10.61, a price-to-earnings-growth ratio of 0.70 and a beta of 1.52. The company has a quick ratio of 1.63, a current ratio of 1.71 and a debt-to-equity ratio of 2.39.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds have recently bought and sold shares of the company. Cetera Investment Advisers raised its stake in Tenet Healthcare by 0.4% during the second quarter. Cetera Investment Advisers now owns 28,924 shares of the company's stock worth $5,091,000 after buying an additional 104 shares during the last quarter. Creative Planning raised its stake in Tenet Healthcare by 7.4% during the second quarter. Creative Planning now owns 14,980 shares of the company's stock worth $2,636,000 after buying an additional 1,035 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Tenet Healthcare by 5.0% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 23,865 shares of the company's stock worth $4,200,000 after buying an additional 1,133 shares during the last quarter. Donoghue Forlines LLC bought a new position in Tenet Healthcare during the second quarter worth $2,947,000. Finally, Oak Harvest Investment Services bought a new position in Tenet Healthcare during the second quarter worth $245,000. Institutional investors own 95.44% of the company's stock.

Insider Activity at Tenet Healthcare

In other news, Director J Robert Kerrey sold 1,222 shares of Tenet Healthcare stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $164.96, for a total transaction of $201,581.12. Following the transaction, the director owned 22,377 shares in the company, valued at approximately $3,691,309.92. The trade was a 5.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Paola M. Arbour sold 7,738 shares of Tenet Healthcare stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $173.00, for a total transaction of $1,338,674.00. Following the transaction, the executive vice president owned 20,110 shares in the company, valued at approximately $3,479,030. This trade represents a 27.79% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 49,120 shares of company stock valued at $8,103,656 in the last quarter. Insiders own 0.81% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.